Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii

References

• Heidary M, Salimi Chirani A, Khoshnood S, et al. Molecular detection of aminoglycoside-modifying enzyme genes in Acinetobacter baumannii clinical isolates. Acta Microbiol Immunol Hung. 2017;64(2):143–150. doi:10.1556/030.63.2016.02227981851
   PubMed Web of Science ®Google Scholar
• Kroger C, Kary SC, Schauer K, Cameron AD. Genetic regulation of virulence and antibiotic resistance in Acinetobacter baumannii. Genes (Basel). 2016;8(1):12. doi:10.3390/genes8010012
   Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009–2012. Int J Antimicrob Agents. 2014;43(4):328–334. doi:10.1016/j.ijantimicag.2014.01.00724630306
   PubMed Web of Science ®Google Scholar
• Asadollahi K, Alizadeh E, Akbari M, et al. The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals. Roum Arch Microbiol Immunol. 2011;70(4):153–158.22568262
   PubMedGoogle Scholar
• Bonnin RA, Nordmann P, Poirel L. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther. 2013;11(6):571–583. doi:10.1586/eri.13.3823750729
   PubMed Web of Science ®Google Scholar
• Boll JM, Crofts AA, Peters K, et al. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Proc Natl Acad Sci U S A. 2016;113(41):E6228–E6237. doi:10.1073/pnas.161159411327681618
   PubMed Web of Science ®Google Scholar
• Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life. 2011;63(12):1061–1067. doi:10.1002/iub.53221990280
   PubMed Web of Science ®Google Scholar
• Gayoso CM, Mateos J, Mendez JA, et al. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res. 2014;13(2):460–476. doi:10.1021/pr400603f24299215
   PubMed Web of Science ®Google Scholar
• China Antimicrobial Resistance Surveillance S. [Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017]. Zhonghua Yi Xue Za Zhi. 2018;98(40):3279–3287. doi:10.3760/cma.j.issn.0376-2491.2018.40.01330392296
   PubMedGoogle Scholar
• Mangoni ML, Bhunia A. Editorial: antimicrobial peptides in medicinal chemistry: advances and applications. Curr Top Med Chem. 2016;16(1):2–3.26391965
   PubMed Web of Science ®Google Scholar
• Lazar V, Martins A, Spohn R, et al. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat Microbiol. 2018;3(6):718–731. doi:10.1038/s41564-018-0164-029795541
   PubMed Web of Science ®Google Scholar
• Pane K, Durante L, Crescenzi O, et al. Antimicrobial potency of cationic antimicrobial peptides can be predicted from their amino acid composition: application to the detection of “cryptic” antimicrobial peptides. J Theor Biol. 2017;419:254–265. doi:10.1016/j.jtbi.2017.02.01228216428
   PubMed Web of Science ®Google Scholar
• Le CF, Fang CM, Sekaran SD. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother. 2017;61(4). doi:10.1128/AAC.02340-16
   Web of Science ®Google Scholar
• Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med. 2004;10(3):310–315. doi:10.1038/nm99614770178
   PubMed Web of Science ®Google Scholar
• Gui S, Li R, Feng Y, Wang S. Transmission electron microscopic morphological study and flow cytometric viability assessment of Acinetobacter baumannii susceptible to Musca domestica cecropin. Scientific World Journal 2014;2014:657536. doi:10.1155/2014/657536
   Google Scholar
• Lu X, Shen J, Jin X, et al. Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli. Appl Microbiol Biotechnol. 2012;95(4):939–945. doi:10.1007/s00253-011-3793-222202966
   PubMed Web of Science ®Google Scholar
• Sang M, Wei H, Zhang J, et al. Expression and characterization of the antimicrobial peptide ABP-dHC-cecropin A in the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 2017;140:44–51. doi:10.1016/j.pep.2017.08.00128827052
   PubMed Web of Science ®Google Scholar
• Thandar M, Lood R, Winer BY, Deutsch DR, Euler CW, Fischetti VA. Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60(5):2671–2679. doi:10.1128/AAC.02972-1526856847
   PubMed Web of Science ®Google Scholar
• Alarcon T, Lopez-Hernandez S, Andreu D, Saugar JM, Rivas L, Lopez-Brea M. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains. Rev Esp Quimioter. 2001;14(2):184–190.11704773
   PubMedGoogle Scholar
• Long H, Yang J, Peng J, Jianwei W. Antimicrobial activity of Musca domestica cecropin - 4 (mdCec 4) against Acinetobacter baumannii. Chin J Microbiol Immunol. 2017;37(12):891–896. doi:10.3760/cma.j.issn.0254-5101.2017.12.002
   Google Scholar
• Liang Y, Wang JX, Zhao XF, Du XJ, Xue JF. Molecular cloning and characterization of cecropin from the housefly (Musca domestica), and its expression in Escherichia coli. Dev Comp Immunol. 2006;30(3):249–257. doi:10.1016/j.dci.2005.04.005
   Google Scholar
• Jin X, Mei H, Li X, et al. Apoptosis-inducing activity of the antimicrobial peptide cecropin of Musca domestica in human hepatocellular carcinoma cell line BEL-7402 and the possible mechanism. Acta Biochim Biophys Sin. 2010;42(4):259–265. doi:10.1093/abbs/gmq02120383464
   PubMedGoogle Scholar
• Lee HW, Koh YM, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect. 2008;14(1):49–54. doi:10.1111/j.1469-0691.2007.01842.x18005176
   PubMed Web of Science ®Google Scholar
• Sahu C, Jain V, Mishra P, Prasad KN. Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI). J Lab Physicians. 2018;10(3):289–293. doi:10.4103/JLP.JLP_176_1730078964
   PubMed Web of Science ®Google Scholar
• Ong ZY, Cheng J, Huang Y, et al. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic beta-sheet forming peptide amphiphiles. Biomaterials. 2014;35(4):1315–1325. doi:10.1016/j.biomaterials.2013.10.05324211081
   PubMed Web of Science ®Google Scholar
• Patra JK, Baek KH. Antibacterial activity and action mechanism of the Essential Oil from Enteromorpha linza L. against foodborne pathogenic bacteria. Molecules. 2016;21(3):388. doi:10.3390/molecules2103038827007365
   PubMed Web of Science ®Google Scholar
• Schneider VA, Coorens M, Ordonez SR, et al. Imaging the antimicrobial mechanism(s) of cathelicidin-2. Sci Rep. 2016;6:32948. doi:10.1038/srep3294827624595
   PubMed Web of Science ®Google Scholar
• Shen Y, Vignali P, Wang R. Rapid profiling cell cycle by flow cytometry using concurrent staining of DNA and mitotic markers. Bio Protoc. 2017;7(16). doi:10.21769/BioProtoc.2517
   Google Scholar
• Mohamed MF, Hamed MI, Panitch A, Seleem MN. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. Antimicrob Agents Chemother. 2014;58(7):4113–4122. doi:10.1128/AAC.02578-1424798285
   PubMed Web of Science ®Google Scholar
• Wei GX, Campagna AN, Bobek LA. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother. 2006;57(6):1100–1109. doi:10.1093/jac/dkl12016595638
   PubMed Web of Science ®Google Scholar
• Kong L, Qi X, Huang S, Chen S, Wu Y, Zhao L. Theaflavins inhibit pathogenic properties of P. gingivalis and MMPs production in P. gingivalis-stimulated human gingival fibroblasts. Arch Oral Biol. 2015;60(1):12–22. doi:10.1016/j.archoralbio.2014.08.01925244614
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson M, Morck D, et al. The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol. 2001;337:377–385.11398443
   PubMed Web of Science ®Google Scholar
• Mohamed MF, Brezden A, Mohammad H, Chmielewski J, Seleem MN. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Sci Rep. 2017;7(1):6953. doi:10.1038/s41598-017-07440-028761101
   PubMed Web of Science ®Google Scholar
• Tucker AT, Leonard SP, DuBois CD, et al. Discovery of next-generation antimicrobials through bacterial self-screening of surface-displayed peptide libraries. Cell. 2018;172(3):618–628 e613. doi:10.1016/j.cell.2017.12.00929307492
   PubMed Web of Science ®Google Scholar
• Dennison SR, Harris F, Mura M, Morton LH, Zvelindovsky A, Phoenix DA. A novel form of bacterial resistance to the action of eukaryotic host defense peptides, the use of a lipid receptor. Biochemistry. 2013;52(35):6021–6029. doi:10.1021/bi400719j23895279
   PubMed Web of Science ®Google Scholar
• Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. 2012;11(1):37–51. doi:10.1038/nrd3591
   Web of Science ®Google Scholar